Review




Structured Review

GenScript corporation surrogate virus neutralization test (svnt) c-pass
Detection of SARS-CoV-2-specific antibodies by <t>sVNT.</t> ( a ) The distribution of negative ( n = 237) and positive serum samples ( n = 35) in surrogate virus <t>neutralization</t> assay (sVNT) with positive–negative cut-off (30%). ( b ) Percentage inhibitions of cat serum samples ( n = 272) determined by sVNT. Based on the cut-off of 30% inhibition, 237 samples are negative, and 35 are positive for SARS-CoV-2 antibodies.
Surrogate Virus Neutralization Test (Svnt) C Pass, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/surrogate+virus+neutralization+test+%28svnt%29+c-pass/pmc10386599-50-4-9?v=GenScript+corporation
Average 90 stars, based on 1 article reviews
surrogate virus neutralization test (svnt) c-pass - by Bioz Stars, 2026-07
90/100 stars

Images

1) Product Images from "SARS-CoV-2 Prevalence and Variant Surveillance among Cats in Pittsburgh, Pennsylvania, USA"

Article Title: SARS-CoV-2 Prevalence and Variant Surveillance among Cats in Pittsburgh, Pennsylvania, USA

Journal: Viruses

doi: 10.3390/v15071493

Detection of SARS-CoV-2-specific antibodies by sVNT. ( a ) The distribution of negative ( n = 237) and positive serum samples ( n = 35) in surrogate virus neutralization assay (sVNT) with positive–negative cut-off (30%). ( b ) Percentage inhibitions of cat serum samples ( n = 272) determined by sVNT. Based on the cut-off of 30% inhibition, 237 samples are negative, and 35 are positive for SARS-CoV-2 antibodies.
Figure Legend Snippet: Detection of SARS-CoV-2-specific antibodies by sVNT. ( a ) The distribution of negative ( n = 237) and positive serum samples ( n = 35) in surrogate virus neutralization assay (sVNT) with positive–negative cut-off (30%). ( b ) Percentage inhibitions of cat serum samples ( n = 272) determined by sVNT. Based on the cut-off of 30% inhibition, 237 samples are negative, and 35 are positive for SARS-CoV-2 antibodies.

Techniques Used: Virus, Neutralization, Inhibition

Comparison of  sVNT  and eLFA.
Figure Legend Snippet: Comparison of sVNT and eLFA.

Techniques Used: Comparison, Inhibition

Detection of SARS-CoV-2-specific antibodies in sVNT-positive (>30% inhibition) cat serum samples using eLFA. The error bar indicates standard error of mean.
Figure Legend Snippet: Detection of SARS-CoV-2-specific antibodies in sVNT-positive (>30% inhibition) cat serum samples using eLFA. The error bar indicates standard error of mean.

Techniques Used: Inhibition

Diagnostic performance of eLFA.
Figure Legend Snippet: Diagnostic performance of eLFA.

Techniques Used: Diagnostic Assay



Similar Products

90
GenScript corporation surrogate virus neutralization test (svnt) c-pass
Detection of SARS-CoV-2-specific antibodies by <t>sVNT.</t> ( a ) The distribution of negative ( n = 237) and positive serum samples ( n = 35) in surrogate virus <t>neutralization</t> assay (sVNT) with positive–negative cut-off (30%). ( b ) Percentage inhibitions of cat serum samples ( n = 272) determined by sVNT. Based on the cut-off of 30% inhibition, 237 samples are negative, and 35 are positive for SARS-CoV-2 antibodies.
Surrogate Virus Neutralization Test (Svnt) C Pass, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/surrogate+virus+neutralization+test+%28svnt%29+c-pass/pmc10386599-50-4-9?v=GenScript+corporation
Average 90 stars, based on 1 article reviews
surrogate virus neutralization test (svnt) c-pass - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

Image Search Results


Detection of SARS-CoV-2-specific antibodies by sVNT. ( a ) The distribution of negative ( n = 237) and positive serum samples ( n = 35) in surrogate virus neutralization assay (sVNT) with positive–negative cut-off (30%). ( b ) Percentage inhibitions of cat serum samples ( n = 272) determined by sVNT. Based on the cut-off of 30% inhibition, 237 samples are negative, and 35 are positive for SARS-CoV-2 antibodies.

Journal: Viruses

Article Title: SARS-CoV-2 Prevalence and Variant Surveillance among Cats in Pittsburgh, Pennsylvania, USA

doi: 10.3390/v15071493

Figure Lengend Snippet: Detection of SARS-CoV-2-specific antibodies by sVNT. ( a ) The distribution of negative ( n = 237) and positive serum samples ( n = 35) in surrogate virus neutralization assay (sVNT) with positive–negative cut-off (30%). ( b ) Percentage inhibitions of cat serum samples ( n = 272) determined by sVNT. Based on the cut-off of 30% inhibition, 237 samples are negative, and 35 are positive for SARS-CoV-2 antibodies.

Article Snippet: Additionally, we utilized the surrogate virus neutralization test (sVNT) (Genscript, c-pass) for serological surveillance of SARS-CoV-2 in cat sera ( n = 272) [ ].

Techniques: Virus, Neutralization, Inhibition

Comparison of  sVNT  and eLFA.

Journal: Viruses

Article Title: SARS-CoV-2 Prevalence and Variant Surveillance among Cats in Pittsburgh, Pennsylvania, USA

doi: 10.3390/v15071493

Figure Lengend Snippet: Comparison of sVNT and eLFA.

Article Snippet: Additionally, we utilized the surrogate virus neutralization test (sVNT) (Genscript, c-pass) for serological surveillance of SARS-CoV-2 in cat sera ( n = 272) [ ].

Techniques: Comparison, Inhibition

Detection of SARS-CoV-2-specific antibodies in sVNT-positive (>30% inhibition) cat serum samples using eLFA. The error bar indicates standard error of mean.

Journal: Viruses

Article Title: SARS-CoV-2 Prevalence and Variant Surveillance among Cats in Pittsburgh, Pennsylvania, USA

doi: 10.3390/v15071493

Figure Lengend Snippet: Detection of SARS-CoV-2-specific antibodies in sVNT-positive (>30% inhibition) cat serum samples using eLFA. The error bar indicates standard error of mean.

Article Snippet: Additionally, we utilized the surrogate virus neutralization test (sVNT) (Genscript, c-pass) for serological surveillance of SARS-CoV-2 in cat sera ( n = 272) [ ].

Techniques: Inhibition

Diagnostic performance of eLFA.

Journal: Viruses

Article Title: SARS-CoV-2 Prevalence and Variant Surveillance among Cats in Pittsburgh, Pennsylvania, USA

doi: 10.3390/v15071493

Figure Lengend Snippet: Diagnostic performance of eLFA.

Article Snippet: Additionally, we utilized the surrogate virus neutralization test (sVNT) (Genscript, c-pass) for serological surveillance of SARS-CoV-2 in cat sera ( n = 272) [ ].

Techniques: Diagnostic Assay